|
1
|
Farrow B, Albo D and Berger DH: The role
of the tumor micro-environment in the progression of pancreatic
cancer. J Surg Res. 149:319–328. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lewin CS, Allen RA and Amyes SG:
Mechanisms of zidovudine resistance in bacteria. J Med Microbiol.
33:235–238. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Coussens LM and Pollard JW: Leukocytes in
mammary development and cancer. Cold Spring Harb Perspect Biol.
3:32011. View Article : Google Scholar
|
|
4
|
Le DT, Lutz E, Uram JN, Sugar EA, Onners
B, Solt S, Zheng L, Diaz LA Jr, Donehower RC, Jaffee EM, et al:
Evaluation of ipilimumab in combination with allogeneic pancreatic
tumor cells transfected with a GM-CSF gene in previously treated
pancreatic cancer. J Immunother. 36:382–389. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Allavena P, Sica A, Solinas G, Porta C and
Mantovani A: The inflammatory micro-environment in tumor
progression: The role of tumor-associated macrophages. Crit Rev
Oncol Hematol. 66:1–9. 2008. View Article : Google Scholar
|
|
6
|
Mantovani A, Sozzani S, Locati M, Allavena
P and Sica A: Macrophage polarization: Tumor-associated macrophages
as a paradigm for polarized M2 mononuclear phagocytes. Trends
Immunol. 23:549–555. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sica A, Schioppa T, Mantovani A and
Allavena P: Tumour-associated macrophages are a distinct M2
polarised population promoting tumour progression: Potential
targets of anti-cancer therapy. Eur J Cancer. 42:717–727. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yoshikawa K, Mitsunaga S, Kinoshita T,
Konishi M, Takahashi S, Gotohda N, Kato Y, Aizawa M and Ochiai A:
Impact of tumor-associated macrophages on invasive ductal carcinoma
of the pancreas head. Cancer Sci. 103:2012–2020. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Greten FR, Eckmann L, Greten TF, Park JM,
Li ZW, Egan LJ, Kagnoff MF and Karin M: IKKbeta links inflammation
and tumorigenesis in a mouse model of colitis-associated cancer.
Cell. 118:285–296. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Karin M and Greten FR: NF-kappaB: Linking
inflammation and immunity to cancer development and progression.
Nat Rev Immunol. 5:749–759. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lin EY, Li JF, Gnatovskiy L, Deng Y, Zhu
L, Grzesik DA, Qian H, Xue XN and Pollard JW: Macrophages regulate
the angiogenic switch in a mouse model of breast cancer. Cancer
Res. 66:11238–11246. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Qian B, Deng Y, Im JH, Muschel RJ, Zou Y,
Li J, Lang RA and Pollard JW: A distinct macrophage population
mediates metastatic breast cancer cell extravasation, establishment
and growth. PLoS One. 4:e65622009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ruffell B, Affara NI and Coussens LM:
Differential macrophage programming in the tumor microenvironment.
Trends Immunol. 33:119–126. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hartupee JC, Zhang H, Bonaldo MF, Soares
MB and Dieckgraefe BK: Isolation and characterization of a cDNA
encoding a novel member of the human regenerating protein family:
Reg IV. Biochim Biophys Acta. 1518:287–293. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Watanabe T, Yonekura H, Terazono K,
Yamamoto H and Okamoto H: Complete nucleotide sequence of human reg
gene and its expression in normal and tumoral tissues. The reg
protein, pancreatic stone protein, and pancreatic thread protein
are one and the same product of the gene. J Biol Chem.
265:7432–7439. 1990.PubMed/NCBI
|
|
16
|
Unno M, Itoh T, Watanabe T, Miyashita H,
Moriizumi S, Teraoka H, Yonekura H and Okamoto H: Islet beta-cell
regeneration and reg genes. Adv Exp Med Biol. 321:61–66; discussion
67–69. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hayashi T, Matsubara A, Ohara S, Mita K,
Hasegawa Y, Usui T, Arihiro K, Norimura S, Sentani K, Oue N, et al:
Immunohistochemical analysis of Reg IV in urogenital organs:
Frequent expression of Reg IV in prostate cancer and potential
utility as serum tumor marker. Oncol Rep. 21:95–100. 2009.
|
|
18
|
Oue N, Hamai Y, Mitani Y, Matsumura S,
Oshimo Y, Aung PP, Kuraoka K, Nakayama H and Yasui W: Gene
expression profile of gastric carcinoma: Identification of genes
and tags potentially involved in invasion, metastasis, and
carcinogenesis by serial analysis of gene expression. Cancer Res.
64:2397–2405. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Oue N, Mitani Y, Aung PP, Sakakura C,
Takeshima Y, Kaneko M, Noguchi T, Nakayama H and Yasui W:
Expression and localization of Reg IV in human neoplastic and
non-neoplastic tissues: Reg IV expression is associated with
intestinal and neuroendocrine differentiation in gastric
adenocarcinoma. J Pathol. 207:185–198. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tamura H, Ohtsuka M, Washiro M, Kimura F,
Shimizu H, Yoshidome H, Kato A, Seki N and Miyazaki M: Reg IV
expression and clinicopathologic features of gallbladder carcinoma.
Hum Pathol. 40:1686–1692. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Violette S1, Festor E, Pandrea-Vasile I,
Mitchell V, Adida C, Dussaulx E, et al: Reg IV, a new member of the
regenerating gene family, is overexpressed in colorectal
carcinomas. Int J Cancer. 103:185–193. 2003. View Article : Google Scholar
|
|
22
|
Legoffic A, Calvo E, Cano C, Folch-Puy E,
Barthet M, Delpero JR, Ferrés-Masó M, Dagorn JC, Closa D and
Iovanna J: The reg4 gene, amplified in the early stages of
pancreatic cancer development, is a promising therapeutic target.
PLoS One. 4:e74952009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
He XJ, Jiang XT, Ma YY, Xia YJ, Wang HJ,
Guan TP, Shao QS and Tao HQ: REG4 contributes to the invasiveness
of pancreatic cancer by upregulating MMP-7 and MMP-9. Cancer Sci.
103:2082–2091. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Takayama R, Nakagawa H, Sawaki A, Mizuno
N, Kawai H, Tajika M, Yatabe Y, Matsuo K, Uehara R, Ono K, et al:
Serum tumor antigen REG4 as a diagnostic biomarker in pancreatic
ductal adenocarcinoma. J Gastroenterol. 45:52–59. 2010. View Article : Google Scholar
|
|
25
|
Rafa L, Dessein AF, Devisme L, Buob D,
Truant S, Porchet N, Huet G, Buisine MP and Lesuffleur T: REG4 acts
as a mitogenic, motility and pro-invasive factor for colon cancer
cells. Int J Oncol. 36:689–698. 2010.PubMed/NCBI
|
|
26
|
Zhang Y, Lai M, Lv B, Gu X, Wang H, Zhu Y,
Zhu Y, Shao L and Wang G: Overexpression of Reg IV in colorectal
adenoma. Cancer Lett. 200:69–76. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bishnupuri KS, Luo Q, Sainathan SK,
Kikuchi K, Sureban SM, Sabarinathan M, et al: Reg IV regulates
normal intestinal and colorectal cancer cell susceptibility to
radiation-induced apoptosis. Gastroenterology. 138:616–626.e2.
2010. View Article : Google Scholar :
|
|
28
|
Tao HQ, He XJ, Ma YY, Wang HJ, Xia YJ, Ye
ZY and Zhao ZS: Evaluation of REG4 for early diagnosis and
prognosis of gastric cancer. Hum Pathol. 42:1401–1409. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kuniyasu H, Oue N, Sasahira T, Yi L,
Moriwaka Y, Shimomoto T, Fujii K, Ohmori H and Yasui W: Reg IV
enhances peritoneal metastasis in gastric carcinomas. Cell Prolif.
42:110–121. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Miyagawa K, Sakakura C, Nakashima S,
Yoshikawa T, Fukuda K, Kin S, Nakase Y, Shimomura K, Oue N, Yasui
W, et al: Overexpression of RegIV in peritoneal dissemination of
gastric cancer and its potential as A novel marker for the
detection of peritoneal micrometastasis. Anticancer Res.
28:1169–1179. 2008.PubMed/NCBI
|
|
31
|
Chanmee T, Ontong P, Konno K and Itano N:
Tumor-associated macrophages as major players in the tumor
microenvironment. Cancers (Basel). 6:1670–1690. 2014. View Article : Google Scholar
|
|
32
|
Pollard JW: Tumour-educated macrophages
promote tumour progression and metastasis. Nat Rev Cancer. 4:71–78.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sica A and Bronte V: Altered macrophage
differentiation and immune dysfunction in tumor development. J Clin
Invest. 117:1155–1166. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mantovani A, Bottazzi B, Colotta F,
Sozzani S and Ruco L: The origin and function of tumor-associated
macrophages. Immunol Today. 13:265–270. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Qian BZ, Li J, Zhang H, Kitamura T, Zhang
J, Campion LR, Kaiser EA, Snyder LA and Pollard JW: CCL2 recruits
inflammatory monocytes to facilitate breast-tumour metastasis.
Nature. 475:222–225. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mantovani A, Savino B, Locati M, Zammataro
L, Allavena P and Bonecchi R: The chemokine system in cancer
biology and therapy. Cytokine Growth Factor Rev. 21:27–39. 2010.
View Article : Google Scholar
|
|
37
|
Zhang J, Patel L and Pienta KJ: CC
chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis
and metastasis. Cytokine Growth Factor Rev. 21:41–48. 2010.
View Article : Google Scholar :
|
|
38
|
Andreu P, Johansson M, Affara NI, Pucci F,
Tan T, Junankar S, Korets L, Lam J, Tawfik D, DeNardo DG, et al:
FcRgamma activation regulates inflammation-associated squamous
carcinogenesis. Cancer Cell. 17:121–134. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
DeNardo DG, Barreto JB, Andreu P, Vasquez
L, Tawfik D, Kolhatkar N and Coussens LM: CD4+ T cells
regulate pulmonary metastasis of mammary carcinomas by enhancing
protumor properties of macrophages. Cancer Cell. 16:91–102. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ruffell D, Mourkioti F, Gambardella A,
Kirstetter P, Lopez RG, Rosenthal N and Nerlov C: A CREB-C/EBPbeta
cascade induces M2 macrophage-specific gene expression and promotes
muscle injury repair. Proc Natl Acad Sci USA. 106:17475–17480.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lanaya H, Natarajan A, Komposch K, Li L,
Amberg N, Chen L, Wculek SK, Hammer M, Zenz R, Peck-Radosavljevic
M, et al: EGFR has a tumour-promoting role in liver macrophages
during hepatocellular carcinoma formation. Nat Cell Biol.
16:972–981. 2014. View Article : Google Scholar :
|
|
42
|
Li YG, Ji DF, Zhong S, Zhu JX, Chen S and
Hu GY: Anti-tumor effects of proteoglycan from Phellinus linteus by
immunomodulating and inhibiting Reg IV/EGFR/Akt signaling pathway
in colorectal carcinoma. Int J Biol Macromol. 48:511–517. 2011.
View Article : Google Scholar : PubMed/NCBI
|
